References
- Rybak LP, Whitworth CA, Mukherjea D, Ramkumar V. Mechanisms of cisplatin-induced ototoxicity and prevention. Hear Res 2007; 226: 157–67
- Aubrecht J, Goad ME, Simpson EM, Schiestl RH. Expression of hygR in transgenic mice causes resistance to toxic effects of hygromycin B in vivo. J Pharmacol Exp Ther 1997; 281: 992–7
- Dulon D, Ryan AF. The bacterial Neo gene confers neomycin resistance to mammalian cochlear hair cells. Neuroreport 1999; 10: 1189–93
- Cappaert NL, Klis SF, Wijbenga J, Smoorenburg GF. Acceleration of cisplatin ototoxicity by perilymphatic application of 4-methylthiobenzoic acid. Hear Res 2005; 203: 80–7
- Chan DK, Lieberman DM, Musatov S, Goldfein JA, Selesnick SH, Kaplitt MG. Protection against cisplatin-induced ototoxicity by adeno-associated virus-mediated delivery of the X-linked inhibitor of apoptosis protein is not dependent on caspase inhibition. Otol Neurotol 2007; 28: 417–25
- Heydt JL, Cunningham LL, Rubel EW, Coltrera MD. Round window gentamicin application: an inner ear hair cell damage protocol for the mouse. Hear Res 2004; 192: 65–74
- Sheppard WM, Wanamaker HH, Pack A, Yamamoto S, Slepecky N. Direct round window application of gentamicin with varying delivery vehicles: a comparison of ototoxicity. Otolaryngol Head Neck Surg 2004; 131: 890–6
- Ding D, Stracher A, Salvi RJ. Leupeptin protects cochlear and vestibular hair cells from gentamicin ototoxicity. Hear Res 2002; 164: 115–26
- Knight KR, Kraemer DF, Neuwelt EA. Ototoxicity in children receiving platinum chemotherapy: underestimating a commonly occurring toxicity that may influence academic and social development. J Clin Oncol 2005; 23: 8588–96
- Ding D, Jiang H, Wang P, Salvi R. Cell death after co-administration of cisplatin and ethacrynic acid. Hear Res 2007; 226: 129–39
- Forge A. Ultrastructure in the stria vascularis of the guinea pig following intraperitoneal injection of ethacrynic acid. Acta Otolaryngol 1981; 92: 439–57
- Nakagawa T, Kim TS, Murai N, Endo T, Iguchi F, Tateya I, et al. A novel technique for inducing local inner ear damage. Hear Res 2003; 176: 122–7
- Lii M, Ding D, Zheng XY, Salvi R. Vestibular destruction by slow infusion of gentamicin into semicircular canals. Acta Otolaryngol Suppl 2004; 552: 35–41
- Sapirstein VS, Flynn C, Lees MB. Developmental changes in carbonic anhydrase and adenylate cyclase in quaking mice. Brain Res 1980; 185: 373–83
- Goycoolea MV, Lundman L. Round window membrane. Structure function and permeability: a review. Microsc Res Tech 1997; 36: 201–11
- Goycoolea MV, Muchow D, Schachern P. Experimental studies on round window structure: function and permeability. Laryngoscope 1988; 98(6 Pt 2 Suppl 44)1–20
- Kalkanis JG, Whitworth C, Rybak LP. Vitamin E reduces cisplatin ototoxicity. Laryngoscope 2004; 114: 538–42
- Minami SB, Sha SH, Schacht J. Antioxidant protection in a new animal model of cisplatin-induced ototoxicity. Hear Res 2004; 198: 137–43
- Hatzopoulos S, Di Stefano M, Campbell KC, Falgione D, Ricci D, Rosignoli M, et al. Cisplatin ototoxicity in the Sprague Dawley rat evaluated by distortion product otoacoustic emissions. Audiology 2001; 40: 253–64
- Laurell G, Ekborn A, Viberg A, Canlon B. Effects of a single high dose of cisplatin on the melanocytes of the stria vascularis in the guinea pig. Audiol Neurootol 2007; 12: 170–8